You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Reducing CV Risk in Patients With Arterial Disease: How Would You Treat?

  • Authors: David A. Morrow, MD, PhD, MPH; Christian Thomas Ruff, MD, PhD, MPH
  • CME / ABIM MOC Released: 11/18/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/18/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists and primary care physicians.

The goal of this activity is to improve clinicians’ ability to treat complex patients with chronic coronary artery disease (CAD).

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Assessing patients to diagnose CAD
    • Tailoring antithrombotic therapy for chronic CAD in patients with comorbidities to reduce the risk for CV events
    • Selecting patient monitoring and follow-up to reduce the risk for CV events in patients with chronic CAD and other comorbidities


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • David A. Morrow, MD, PhD, MPH

    Director, Cardiac Intensive Care Unit, Brigham and Women’s Hospital
    Professor of Medicine, Harvard Medical School
    Boston, Massachusetts

    Disclosures

    Disclosure: David A. Morrow, MD, PhD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca; Bayer; InCarda; Merck & Co., Inc.; Novartis; Roche
    Other: Member of the TIMI Study Group, which was received institutional research grant support through Brigham and Women’s Hospital from Abbott; Amgen; Anthos Therapeutics; AstraZeneca; Daiichi Sankyo; Eisai; Intarcia; MedImmune; Merck & Co., Inc; Novartis; Pfizer; Regeneron; Roche; The Medicines Company; Zora Biosciences

  • Christian Thomas Ruff, MD, PhD, MPH

    Director of General Cardiology, Cardiovascular Division at Brigham and Women’s Hospital
    Associate Professor of Medicine, Harvard Medical School
    Boston, Massachusetts

    Disclosures

    Disclosure: Christian Thomas Ruff, MD, PhD, MPH, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Anthos; Bayer; Bristol Myers Squibb Company; Boehringer Ingelheim; Daiichi Sankyo; Janssen; Pfizer; Portola
    Received grants for clinical research from: Anthos; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo

Editors

  • Gwen Littman, MD

    Scientific Director, Medscape, LLC 

    Disclosures

    Disclosure: Gwen Littman, MD, has disclosed no relevant financial relationships.  

  • Clinton W. Wright, PharmD, BCPP

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Clinton W. Wright, PharmD, BCPP, has disclosed no relevant financial relationships.

  • Terra Sumstine

    Writer, Chichester Associates Inc, Phoenix, Arizona

    Disclosures

    Disclosure: Terra Sumstine has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Reducing CV Risk in Patients With Arterial Disease: How Would You Treat?

Authors: David A. Morrow, MD, PhD, MPH; Christian Thomas Ruff, MD, PhD, MPHFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 11/18/2021

Valid for credit through: 11/18/2022

processing....

ABOUT THIS ACTIVITY
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

Did you know that patients with Coronary Artery Disease who have already controlled their standard risk factors (ie, blood pressure, dyslipidemia, obesity, tobacco use, glycemic control) can do even more to lower their risk of future adverse vascular events?  Learn about the COMPASS trial results and the newest strategies for secondary cardiovascular prevention.

patient simulation